pharma · Alzheimer Disease · Pulmonary Fibrosis
Shanghai University of
Shanghai University of Traditional Chinese Medicine
Shanghai University of trial registry — 24 ClinicalTrials.gov studies with program phase, status, and indication context.
Shanghai, China, CN HQ
6 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Shanghai, China, CN
- Employees
- 6
- Programs
- 24
- Drugs
- 33
- Patents
- 0
Shanghai University of clinical trials
Registry index of 24 ClinicalTrials.gov studies linked to Shanghai University of programs — each row shows trial ID, program name, phase, status, and indication.
Shanghai University of trial registry — 24 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Shanghai University of.
-
YZJ-1139 tablets — Phase 1
Clinical update -
TQB2825 Injection (Subcutaneous Injection) — Phase 1
Clinical update -
Sodium Thiosulfate Injection — Phase 3
Clinical update -
SCT-001 CAR-T cells — Phase 1
Clinical update -
Recombinant Humanized Anti-IL-36R Monoclonal antibody and Placebo — Phase 1
Clinical update -
JWCAR029 (CD19-targeted Chimeric Antigen Receptor Cells) — Phase 1
Clinical update -
Donepezil Dihydroxynaphthalate for Injection — Phase 1
Clinical update -
cis Platinum/Carboplatin, Pemetrexed Disodium — Phase 2
Clinical update